8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane

C17H28N4 — CID 103016553

IUPAC8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane
SMILESCn1nccc1CCN1CC2(CCCC2)NCC1C1CC1
InChIInChI=1S/C17H28N4/c1-20-15(6-10-19-20)7-11-21-13-17(8-2-3-9-17)18-12-16(21)14-4-5-14/h6,10,14,16,18H,2-5,7-9,11-13H2,1H3
InChIKeyYPRLEGJLPBLQPJ-UHFFFAOYSA-N
MW288.44 g/mol
LogP1.96
Rot. Bonds4

About 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane

8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane (PubChem CID 103016553) has the molecular formula C17H28N4 and a molecular weight of 288.44 g/mol. Its IUPAC name is 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane.

Molecular Properties

Compound Name8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane
PubChem CID103016553
Molecular FormulaC17H28N4
Molecular Weight288.44 g/mol
Exact Mass288.23
IUPAC Name8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane
SMILESCn1nccc1CCN1CC2(CCCC2)NCC1C1CC1
InChIInChI=1S/C17H28N4/c1-20-15(6-10-19-20)7-11-21-13-17(8-2-3-9-17)18-12-16(21)14-4-5-14/h6,10,14,16,18H,2-5,7-9,11-13H2,1H3
InChIKeyYPRLEGJLPBLQPJ-UHFFFAOYSA-N
XLogP1.96
TPSA33.09 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500288.44
LogP ≤ 51.96
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

8-ethyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane
CID 103016543
8-cyclopropyl-9-(pyridin-4-ylmethyl)-6,9-diazaspiro[4.5]decane
CID 64877763
9-[(4-chlorophenyl)methyl]-8-cyclopropyl-6,9-diazaspiro[4.5]decane
CID 64877376
8-cyclopropyl-9-[(2-methyltetrazol-5-yl)methyl]-6,9-diazaspiro[4.5]decane
CID 107055892
3-cyclopropyl-4-[(1-methylpyrazol-3-yl)methyl]-1,4-diazaspiro[5.5]undecane
CID 82872339
5,5-diethyl-2-methyl-1-[2-(2-methylpyrazol-3-yl)ethyl]piperazine
CID 103016611
3,3,7-trimethyl-1-[2-(2-methylpyrazol-3-yl)ethyl]-1,4-diazepane
CID 103016739
9-[(4-bromothiophen-2-yl)methyl]-8-cyclopropyl-6,9-diazaspiro[4.5]decane
CID 64875648
8-methyl-9-(2-pyridin-4-ylethyl)-6,9-diazaspiro[4.5]decane
CID 64933810
3-cyclopropyl-4-(2-propoxyethyl)-1,4-diazaspiro[5.5]undecane
CID 106458748
2-methyl-1-[2-(2-methylpyrazol-3-yl)ethyl]cyclohexan-1-ol
CID 103005724
9-[(5-bromo-3-pyridinyl)methyl]-8-cyclopropyl-6,9-diazaspiro[4.5]decane
CID 104812533

Frequently Asked Questions

What is the IUPAC name of 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane?
The IUPAC name of 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane (CID 103016553) is 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane.
What is the SMILES notation for 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane?
The canonical SMILES for 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane is Cn1nccc1CCN1CC2(CCCC2)NCC1C1CC1.
What is the InChIKey of 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane?
The InChIKey is YPRLEGJLPBLQPJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H28N4/c1-20-15(6-10-19-20)7-11-21-13-17(8-2-3-9-17)18-12-16(21)14-4-5-14/h6,10,14,16,18H,2-5,7-9,11-13H2,1H3.
What are the key properties of 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane?
8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane has a molecular weight of 288.44 g/mol, XLogP of 1.96, 4 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 8-cyclopropyl-9-[2-(2-methylpyrazol-3-yl)ethyl]-6,9-diazaspiro[4.5]decane is sourced from PubChem (CID 103016553), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).